Herriot Tabuteau
Chief Executive Officer, Director, 10% Owner · Axsome Therapeutics, Inc.
- 2025
- Aug 7, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Herriot Tabuteau files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nick Pizzie - $10.18M in AXSM purchases and sales in the last 12 months
- Mark L. Jacobson - $8.90M in AXSM purchases and sales in the last 12 months
- Mark Coleman - $8.21M in AXSM purchases and sales in the last 12 months
- Mark E. Saad - $6.21M in AXSM purchases and sales in the last 12 months
- Ari Maizel - $2.75M in AXSM purchases and sales in the last 12 months
- Susan Mahony - $145K in AXSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Herriot Tabuteau?
Herriot Tabuteau is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of Axsome Therapeutics, Inc. (AXSM). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Herriot Tabuteau submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Herriot Tabuteau been buying or selling stock?
Recorded transactions: 0 open-market purchases and 20 open-market sales ($110.58M) across all tracked filings.
